Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Fall 2014 - Innovation
Download Issue
Share
Up Front
Publisher's Corner
Healthcare Solutions: Peering Into the Future
By Patrick M. Schmidt
Features
The Age of Telemedicine
By
Amy Scanlin, MS
Alzheimer’s: Can It Be Stopped?
By
Ronale Tucker Rhodes, MS
Regenerative Medicine: Are We There?
By
Ronale Tucker Rhodes, MS
21st Century Medicine: Now It’s Personal
By
Trudie Mitschang
Myths and Facts: von Willebrand Disease
By
Ronale Tucker Rhodes, MS
BioTrends Watch
Washington Report
HHS to Enforce Orphan Exclusion Rule for 340B Drug Discounts
Lower Medicare Spending Means Enhanced Financial Future
ACA Insurance Subsidies Struck Down by D.C. Appeals Court
CMS Proposed Rule Will Extend EHR Incentive Program
Round Two Recipients Chosen for Health Care Innovation Awards
Reimbursement FAQs
Specialty Pharmacies and Delivery Models
Industry News
New Therapy Requires Less Frequent Dosing for Hemophilia B Patients
rFVIII Treatment for Hemophilia A Receives Positive Results
Study Finds Vaccine Side Effects Extremely Rare
Vaccine Update
FDA Approves Tivorbex
Site Advocacy Group Initiative Launched for Clinical Research
ACIP Urges Nasal Spray Flu Vaccine for Children
FDA Approves Needle-Free Injector for Afluria Flu Vaccine
FDA Approves Baxter's HYQVIA for Treatment of PI
CSL Enrolls First Patient in Study of rVIII-SingleChain
Ebola Vaccine to Be Tested in Humans
Vaccination Coverage Among Kids 13-17 Rises
CDC Announces Recent Flu Season Numbers
BioFocus
Industry Insight
Long-Acting Factor Concentrates: The Next Leap Forward in Hemophilia Care Arrives
By Keith Berman, MPH, MBA
Patient Profile
Stroke Prevention: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Stroke Prevention: A Physician's Perspective
By Trudie Mitschang
BioSources
BioResearch
Protein C Concentrate Added to Standard Therapy May Reduce Mortality Risk in Sepsis-Induced Purpura Fulminans
High-Dose IVIG Associated with Improved Recovery of Left Ventrical Function in Acute Myocarditis and/or Early DCM